Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)

Innovative Neulasta® Onpro® Kit is Designed to Provide the Right Dose for Patients at the Right Time THOUSAND OAKS, Calif., Feb. 27, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that the Committee for M... Biopharmaceuticals, Drug Delivery, Regulatory Amgen, Neulasta, pegfilgrastim, Neulasta Onpro Kit, neutropenia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news